Mahmood Barani

6.7k citations

121 papers · 5.1k indexed · 4 hit papers · h-index 42

Co-authors: Abbas Rahdar George Z. Kyzas Muhammad Bilal Masoud Torkzadeh‐Mahani Saman Sargazi Mohammad Mirzaei Sadanand Pandey Fakhara Sabir
Topics: Nanoparticle-Based Drug Delivery (32 papers)Nanoplatforms for cancer theranostics (18 papers)Nanoparticles: synthesis and applications (18 papers)
Cited by: Biomaterials Pharmaceutical Science Molecular Medicine
Journals: Scientific Reports International Journal of Molecular Sciences Nanoscale
Partner nations: Iran Pakistan China

In The Last Decade

Mahmood Barani

116 papers receiving 5.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Stimuli-Responsive Polymeric Nanocarriers for Drug Delivery, Imaging, and Theragnosis

2020 377 citations Muhammad Bilal, Mahmood Barani et al. Polymers profile →
Polyacrylic Acid Nanoplatforms: Antimicrobial, Tissue Engineering, and Cancer Theranostic Applications

2022 169 citations Mahmood Barani, Narendra Pal Singh Chauhan et al. Polymers profile →
Biopolymer-based composites for tissue engineering applications: A basis for future opportunities

2023 132 citations Payam Zarrintaj, Farzad Seidi et al. Composites Part B Engineering profile →
Applications of plant-based nanoparticles in nanomedicine: A review

2022 127 citations Vahideh Mohammadzadeh, Mahmood Barani et al. profile →

Peers

Countries citing papers authored by Mahmood Barani

Since Specialization

Citations

This map shows the geographic impact of Mahmood Barani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mahmood Barani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mahmood Barani more than expected).

Fields of papers citing papers by Mahmood Barani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mahmood Barani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mahmood Barani. The network helps show where Mahmood Barani may publish in the future.

Co-authorship network of co-authors of Mahmood Barani

This figure shows the co-authorship network connecting the top 25 collaborators of Mahmood Barani. A scholar is included among the top collaborators of Mahmood Barani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mahmood Barani. Mahmood Barani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Green synthesis of ZIF-67 nanoparticles via microfluidics: Towards sustainable nanomaterial production 2024 ·Journal of Molecular Liquids ·(unknown),(unknown),(unknown),Mahmood Barani,(unknown)	6
2	Study of cytotoxic performance of green-synthesized Co doped NiO nanoparticles over human breast cancer cells 2024 ·Inorganic Chemistry Communications ·Khadijeh Hamidian,(unknown),Mina Sarani,Mahmood Barani,Mahboubeh Adeli‐Sardou	10
3	Facile synthesis of Tl, Pb, and Bi doped CeO2 nanoparticles and the evaluation of their in-vitro cytotoxicity and photocatalytic performance 2024 ·Journal of the Indian Chemical Society ·Mina Sarani,Majid Darroudi,Mahmood Barani,Faeze Khakbaz,Zahra Sabouri,(unknown),(unknown)	3
4	Enhanced pollutant degradation via green-synthesized core-shell mesoporous Si@Fe magnetic nanoparticles immobilized with metagenomic laccase 2024 ·International Journal of Biological Macromolecules ·Shohreh Ariaeenejad,Mahmood Barani,Maryam Roostaee,Azadeh Lohrasbi‐Nejad,Ghasem Mohammadi‐Nejad,Ghasem Hosseini Salekdeh	11
5	Advancements in nanoparticle-based therapies for multidrug-resistant candidiasis infections: a comprehensive review 2024 ·Nanotechnology ·Alireza Izadi,(unknown),Maryam Roostaee,Seyyed Amin Ayatollahi Mousavi,Mahmood Barani	6
6	Biocatalytic decolorization of azo dye-containing wastewater by immobilizing metagenome-derived laccase on green synthesized Co-doped NiO NPs 2023 ·Process Safety and Environmental Protection ·Shohreh Ariaeenejad,Mahmood Barani,Mina Sarani,Azadeh Lohrasbi‐Nejad,Ghasem Mohammadi‐Nejad,Ghasem Hosseini Salekdeh	9
7	Preparation, characterization, cytotoxicity and pharmacokinetics of niosomes containing gemcitabine: In vitro, in vivo, and simulation studies 2023 ·Journal of Drug Delivery Science and Technology ·Mahmood Barani,Mohammad Reza Hajinezhad,Farshid Zargari,(unknown),Fatemeh Davodabadi,Shekoufeh Mirinejad,Saman Sargazi,Abbas Rahdar,Ana M. Díez‐Pascual	20
8	Biopolymer-based composites for tissue engineering applications: A basis for future opportunitiesbreakdown → 2023 ·Composites Part B Engineering ·Payam Zarrintaj,Farzad Seidi,(unknown),Mohsen Khodadadi Yazdi,Amir Erfani,Mahmood Barani,Narendra Pal Singh Chauhan,Navid Rabiee,Tairong Kuang,Justyna Kucińska‐Lipka,Mohammad Reza Saeb,Masoud Mozafari	132
9	Nano-Based Theranostic Platforms for Breast Cancer: A Review of Latest Advancements 2022 ·Bioengineering ·Rabia Arshad,Maria Hassan Kiani,Abbas Rahdar,Saman Sargazi,Mahmood Barani,(unknown),Muhammad Bilal,Deepak Kumar,Sadanand Pandey	40
10	Nanomaterials in the Management of Gram-Negative Bacterial Infections 2021 ·Nanomaterials ·Mahmood Barani,Mahira Zeeshan,Davood Kalantar-Neyestanaki,Muhammad Asim Farooq,Abbas Rahdar,Niraj Kumar Jha,Saman Sargazi,Piyush Kumar Gupta,Vijay Kumar Thakur	33
11	Simulation, In Vitro, and In Vivo Cytotoxicity Assessments of Methotrexate-Loaded pH-Responsive Nanocarriers 2021 ·Polymers ·Mahmood Barani,Mohammad Reza Hajinezhad,Saman Sargazi,Mahira Zeeshan,Abbas Rahdar,Sadanand Pandey,Mehrdad Khatami,Farshid Zargari	38
12	Active Targeted Nanoparticles for Delivery of Poly(ADP-ribose) Polymerase (PARP) Inhibitors: A Preliminary Review 2021 ·International Journal of Molecular Sciences ·Saman Sargazi,Mahwash Mukhtar,Abbas Rahdar,Mahmood Barani,Sadanand Pandey,Ana M. Díez‐Pascual	33
13	DNA Based and Stimuli-Responsive Smart Nanocarrier for Diagnosis and Treatment of Cancer: Applications and Challenges 2021 ·Cancers ·Fakhara Sabir,Mahira Zeeshan,Ushna Laraib,Mahmood Barani,Abbas Rahdar,Magali Cucchiarini,Sadanand Pandey	64
14	F127/Cisplatin Microemulsions: In Vitro, In Vivo and Computational Studies 2021 ·Applied Sciences ·Saman Sargazi,Mohammad Reza Hajinezhad,Mahmood Barani,Mahwash Mukhtar,Abbas Rahdar,Francesco Baino,Pouya Karimi,Sadanand Pandey	20
15	Recent Advances in Nanotechnology-Based Diagnosis and Treatments of Human Osteosarcoma 2021 ·Biosensors ·Mahmood Barani,Mahwash Mukhtar,Abbas Rahdar,Saman Sargazi,Sadanand Pandey,Misook Kang	78
16	Nanomaterials for the Diagnosis and Treatment of Head and Neck Cancers: A Review 2021 ·Materials ·Gustavo Ruiz-Pulido,Dora I. Medina,Mahmood Barani,Abbas Rahdar,Ghasem Sargazi,Francesco Baino,Sadanand Pandey	31
17	Theranostic Advances of Bionanomaterials against Gestational Diabetes Mellitus: A Preliminary Review 2021 ·Journal of Functional Biomaterials ·Mahmood Barani,Saman Sargazi,Vahideh Mohammadzadeh,Abbas Rahdar,Sadanand Pandey,Niraj Kumar Jha,Piyush Kumar Gupta,Vijay Kumar Thakur	24
18	Polylysine for skin regeneration: A review of recent advances and future perspectives 2021 ·Bioengineering & Translational Medicine ·Payam Zarrintaj,Sadegh Ghorbani,Mahmood Barani,Narendra Pal Singh Chauhan,Mohsen Khodadadi Yazdi,Mohammad Reza Saeb,Joshua D. Ramsey,Michael R. Hamblin,Masoud Mozafari,Ebrahim Mostafavi	54
19	Nanotechnology in Bladder Cancer: Diagnosis and Treatment 2021 ·Cancers ·Mahmood Barani,Seyedeh Maryam Hosseinikhah,Abbas Rahdar,(unknown),Rabia Arshad,Magali Cucchiarini,Sadanand Pandey	72
20	How to Face Skin Cancer with Nanomaterials: A Review 2020 ·Biointerface Research in Applied Chemistry ·Fakhara Sabir,Mahmood Barani,Abbas Rahdar,Muhammad Bilal,Muhammad Nadeem Zafar,Simona Bungău,George Z. Kyzas,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown)	35

About Mahmood Barani

Mahmood Barani is a scholar working on Pharmaceutical Science, Biomaterials and Molecular Medicine, having authored 121 papers that have together received 5.1k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (32 papers), Nanoplatforms for cancer theranostics (18 papers) and Nanoparticles: synthesis and applications (18 papers). The work is most often cited by research in Biomaterials (1.5k citations), Pharmaceutical Science (659 citations) and Molecular Medicine (282 citations). Mahmood Barani has collaborated with scholars based in Iran, Pakistan and China. Frequent co-authors include Abbas Rahdar, George Z. Kyzas, Muhammad Bilal, Masoud Torkzadeh‐Mahani, Saman Sargazi, Mohammad Mirzaei, Sadanand Pandey, Fakhara Sabir, Mohammad Hadi Nematollahi and Rabia Arshad. Their work appears in journals such as Scientific Reports, International Journal of Molecular Sciences and Nanoscale.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact